These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14468640)

  • 1. Preservation of guinea-pig serum complement for its use in properdin assay using inulin.
    MAJUMDAR AC; SEN R; MUKERJI B
    Ann Biochem Exp Med; 1962 Aug; 22():209-12. PubMed ID: 14468640
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the properdin level with the aid of inulin and dry guinea pig complement].
    IAKOVLEV AM; KOMLEVA GG; IAKOVLEVA SD
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Nov; 31():58-63. PubMed ID: 13717218
    [No Abstract]   [Full Text] [Related]  

  • 3. Research on the properdin system. I. Inactivation of the third complement component through zymosan on inulin.
    HEISE ER
    Klin Wochenschr; 1958 Jan; 36(2):88-9. PubMed ID: 13540126
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V; Nicholson A; Lee GD; Mayer MM
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of Guinea pig properidin.
    Nicholson A; Austen KF
    J Immunol; 1977 Jan; 118(1):103-8. PubMed ID: 830742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relation between properdinemia and alexinemia in the guinea pig].
    DIACONO H; CASTAY M
    C R Seances Soc Biol Fil; 1960; 154():334-5. PubMed ID: 13816508
    [No Abstract]   [Full Text] [Related]  

  • 8. Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid.
    Vogt W; Schmidt G; Lynen R; Dieminger L
    J Immunol; 1975 Feb; 114(2 Pt 1):671-7. PubMed ID: 804510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunochemical studies on the mechanism of allergic diseases. II. The complement and properdin titer of sensitized and anaphylactic shock-exposed guinea pigs].
    DRESSLER O
    Z Immun exp ther; 1959 Sep; 118():175-80. PubMed ID: 13818067
    [No Abstract]   [Full Text] [Related]  

  • 10. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
    Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
    J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).
    Brade V; Cook CT; Shin HS; Mayer MM
    J Immunol; 1972 Dec; 109(6):1174-81. PubMed ID: 4628703
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.
    Brade V; Bentley C; Bitter-Suermann D; Hadding U
    Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):402-14. PubMed ID: 556571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
    Stitzel AE; Spitzer RE
    J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of factor B and C3 in guinea pig serum by zymosan or by activated properdin depends on the presence of factor D.
    Brade V; Bentley C; Kossorotow A; Bitter-Suermann D
    Monogr Allergy; 1977; 12():83-5. PubMed ID: 917024
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Cleavage of the third complement component (C3) and release of a spasmogenic, C3-derived peptide (C3a) by epsilon-aminocaproic acid (EACA) in serum: a process involving the complement activating properdin system.
    Vogt W; Schmidt G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R103. PubMed ID: 4276668
    [No Abstract]   [Full Text] [Related]  

  • 17. Some observations on the properdin system. 8. Properdin and its relation to blood constituents of human and some laboratory animals.
    Majumdar AC; Datta TK; Sarma AK; Ray MK
    J Indian Med Assoc; 1972 Nov; 59(10):428-31. PubMed ID: 4658784
    [No Abstract]   [Full Text] [Related]  

  • 18. An alternative mechanism for the properdin system.
    NELSON RA
    J Exp Med; 1958 Oct; 108(4):515-35. PubMed ID: 13575682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by cinnarizine of the properdin-dependent activation of complement.
    Di Perri T; Auteri A; Pasini FL; Mattioli F
    Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):281-5. PubMed ID: 879911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.